{"DataElement":{"publicId":"3183645","version":"1","preferredName":"Person Abdominal Cavity Fistula Perforation Abscess Clinical Trial Eligibility Criteria Ind-2","preferredDefinition":"the yes/no indicator whether a person has abdominal fistula, an abnormal communication most commonly seen between two internal organs, perforation; a hole made through a part or substance, or abscess, an accumulation of purulent material in tissues, organs, or circumscribed spaces, usually associated with signs of infection, as an element of a personal medical history which are necessary to allow an individual to participate in a specific clinical trial.","longName":"3183644v1.0:2018257v1.0","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"3183644","version":"1","preferredName":"Person Abdominal Cavity Fistula Perforation Abscess Clinical Trial Eligibility Criteria","preferredDefinition":"information related to a person having abdominal fistula, an abnormal communication most commonly seen between two internal organs, perforation; a hole made through a part or substance, or abscess, an accumulation of purulent material in tissues, organs, or circumscribed spaces, usually associated with signs of infection, as an element of a personal medical history which are necessary to allow an individual to participate in a specific clinical trial.","longName":"2236731v1.0:3183642v1.0","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2236731","version":"1","preferredName":"Person","preferredDefinition":"A human being.","longName":"C25190","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Person","conceptCode":"C25190","definition":"A human being.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F9FC6DF7-66EB-4CAB-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-20","endDate":null,"createdBy":"UMLLOADER_MAGE","dateCreated":"2005-06-20","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"3183642","version":"1","preferredName":"Abdominal Cavity Fistula Perforation Abscess Clinical Trial Eligibility Criteria","preferredDefinition":"That portion of the body that lies between the thorax and the pelvis.:Abnormal communication most commonly seen between two internal organs, or between an internal organ and the surface of the body.:Perforation; a hole made through a part or substance. (On-line Medical Dictionary):Accumulation of purulent material in tissues, organs, or circumscribed spaces, usually associated with signs of infection.:Elements of a personal medical history which are necessary to allow an individual to participate in a specific clinical trial.","longName":"3183642v1.0","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Abdomen","conceptCode":"C12664","definition":"The cavity located between the lungs and pelvis. It contains the lower esophagus, stomach, pancreas, intestines, liver, gallbladder and spleen.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Fistula","conceptCode":"C3045","definition":"Abnormal epithelial-lined communication between two anatomical structures.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Perforation","conceptCode":"C4080","definition":"A hole or opening made through a membrane or other tissue or material.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Abscess","conceptCode":"C26686","definition":"An inflammatory process characterized by the accumulation of pus within a newly formed tissue cavity which is the result of a bacterial, fungal, or parasitic infection or the presence of a foreign body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Clinical Trial Eligibility Criteria","conceptCode":"C16112","definition":"Characteristics which are necessary to allow a subject to participate in a clinical study, as outlined in the study protocol. The concept covers inclusion and exclusion criteria.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9A0FA861-F826-7C4F-E040-BB89AD437554","latestVersionIndicator":"Yes","beginDate":"2011-01-17","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2011-01-17","modifiedBy":"ONEDATA","dateModified":"2011-01-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008525","version":"1","preferredName":"Eligibility","preferredDefinition":"trial-specific criteria that a patient must meet to be enrolled.","longName":"ELIG","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1EC3968-9F25-305A-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-16","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-16","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9A0FA861-F837-7C4F-E040-BB89AD437554","latestVersionIndicator":"Yes","beginDate":"2011-01-17","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2011-01-17","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3506068","version":"1","preferredName":"Yes No Indicator","preferredDefinition":"The preferred Value Domain to indicate a question with permissible values of yes/no.","longName":"YES_NO_IND","context":"NCI Standards","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"2","maxLength":"3","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"No","valueDescription":"No","ValueMeaning":{"publicId":"3197154","version":"1","preferredName":"No","longName":"3197154","preferredDefinition":"The non-affirmative response to a question.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"No","conceptCode":"C49487","definition":"The non-affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9D865DE5-55AD-1AC9-E040-BB89AD436B4F","latestVersionIndicator":"Yes","beginDate":"2011-03-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2011-03-02","modifiedBy":"SOKKERL","dateModified":"2023-12-05","changeDescription":null,"administrativeNotes":"2022.12.28 Alt VM added per ticket request CADSR0001837. aj","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C37A1BEB-75C2-B6C9-E040-BB89AD434179","beginDate":"2012-06-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-06-27","modifiedBy":"ONEDATA","dateModified":"2012-06-27","deletedIndicator":"No"},{"value":"Yes","valueDescription":"Yes","ValueMeaning":{"publicId":"3197153","version":"1","preferredName":"Yes","longName":"3197153v1.00","preferredDefinition":"The affirmative response to a question.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Yes","conceptCode":"C49488","definition":"The affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9D865DE5-558A-1AC9-E040-BB89AD436B4F","latestVersionIndicator":"Yes","beginDate":"2011-03-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2011-03-02","modifiedBy":"SOKKERL","dateModified":"2023-12-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C37A1BEB-75CC-B6C9-E040-BB89AD434179","beginDate":"2012-06-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-06-27","modifiedBy":"ONEDATA","dateModified":"2012-06-27","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"3502157","version":"1","preferredName":"Yes No Indicator Value Domains","preferredDefinition":"Conceptual domain that includes value meanings to be used for Indicator Value Meanings such as Yes, No, Unknown, No Applicable","longName":"YES_NO_IND_VD","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C377DE0C-8C3E-DCA8-E040-BB89AD431B6D","latestVersionIndicator":"Yes","beginDate":"2012-06-27","endDate":null,"createdBy":"CURTIST","dateCreated":"2012-06-27","modifiedBy":"CURTIST","dateModified":"2012-06-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2421125","version":"1","preferredName":"Ind-2","preferredDefinition":"A caDSR representation term that is used to indicate a question with permissible values of yes/no","longName":"C38147","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Yes or No Response","conceptCode":"C38147","definition":"A response or indicator that can have a value of either yes or no.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RETIRED ARCHIVED","registrationStatus":"Retired","id":"0303DF01-F4B4-15EC-E044-0003BA3F9857","latestVersionIndicator":"No","beginDate":"2005-10-18","endDate":"2016-04-27","createdBy":"SHIDED","dateCreated":"2005-10-18","modifiedBy":"TAYLORT","dateModified":"2020-10-03","changeDescription":"10.3.20 TL changed WFS from RETIRED PHASED OUT to RETIRED ARCHIVED. Changed Workflow Status DBW 04-27-2016","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Standard","id":"C37A1BEB-75AE-B6C9-E040-BB89AD434179","latestVersionIndicator":"Yes","beginDate":"2012-06-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-06-27","modifiedBy":"TSESU","dateModified":"2023-08-16","changeDescription":"8/29/17 tt added CSI per Round 5 finalization task. 3/12/17 jk added Standard reg status; ownership transfered from CTEP to NCI Standards with concurrence of CTEP/Brian Campbell. jk","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2961451","version":"1","longName":"Children's Oncology Group (COG)","context":"COG","ClassificationSchemeItems":[{"publicId":"3303197","version":"1","longName":"Phase 1/Pilot Consortium","context":"COG"}]},{"publicId":"4057943","version":"1","longName":"Disease Site","context":"NRG","ClassificationSchemeItems":[{"publicId":"4104889","version":"1","longName":"GOG-0229K","context":"NRG"},{"publicId":"4104903","version":"1","longName":"GOG-0170R","context":"NRG"},{"publicId":"10000427","version":"1","longName":"GOG-0170R","context":"NRG"},{"publicId":"10000426","version":"1","longName":"GOG-0170R","context":"NRG"},{"publicId":"4104890","version":"1","longName":"GOG-0229L","context":"NRG"},{"publicId":"10000081","version":"1","longName":"GOG-0186J","context":"NRG"},{"publicId":"4104906","version":"1","longName":"GOG-0186J","context":"NRG"},{"publicId":"10000082","version":"1","longName":"GOG-0186J","context":"NRG"},{"publicId":"10000346","version":"1","longName":"GOG-0186K","context":"NRG"},{"publicId":"10000345","version":"1","longName":"GOG-0186K","context":"NRG"},{"publicId":"4104907","version":"1","longName":"GOG-0186K","context":"NRG"},{"publicId":"10000430","version":"1","longName":"GOG-0186I","context":"NRG"},{"publicId":"10000429","version":"1","longName":"GOG-0186I","context":"NRG"},{"publicId":"4104905","version":"1","longName":"GOG-0186I","context":"NRG"},{"publicId":"4104891","version":"1","longName":"GOG-0229N","context":"NRG"}]}],"AlternateNames":[{"name":"NRG","type":"USED_BY","context":"NRG"},{"name":"3183644v1.0:2018257v1.0","type":"USED_BY","context":"COG"},{"name":"3183644v1.0:2018257v1.0","type":"USED_BY","context":"NRG"},{"name":"3183644v1.0:2018257v1.0","type":"USED_BY","context":"Alliance"},{"name":"COG","type":"USED_BY","context":"COG"},{"name":"ABDOM_FIST_PERFOR_IND2","type":"Context Short Name","context":"NRG"}],"ReferenceDocuments":[{"name":"Does the patient have a histo","type":"Preferred Question Text","description":"Does the patient have a history of abdominal fistula, gastrointestinal perforation, intra-abdominal abscess within 28 days prior to first day of study therapy or an underlying lesion(s) that caused the fistula or perforation in the past that have not been corrected?","url":null,"context":"CTEP"},{"name":"CRF Text2","type":"Alternate Question Text","description":"Does the patient have a history of abdominal fistula, gastrointestinal perforation or intra-abdominal abscess?","url":null,"context":"CTEP"},{"name":"CRF Text","type":"Alternate Question Text","description":"Does the patient have a history of fistula, intra-abdominal abscess or bowel perforation within 6 months prior to first day of study therapy?","url":null,"context":"CTEP"},{"name":"CRF Text4","type":"Alternate Question Text","description":"Does the patient require total parenteral nutrition or parenteral hydration","url":null,"context":"CTEP"},{"name":"CRF Text5","type":"Alternate Question Text","description":"Does the patient require parenteral hydration or parenteral/total parenteral nutrition?","url":null,"context":"CTEP"},{"name":"CRF Text6","type":"Alternate Question Text","description":"Did the patient have abdominal fistula, gastrointestinal perforation, bowel obstruction or gastric outlet obstruction, intra-abdominal abscess within 6 months of registration?","url":null,"context":"CTEP"},{"name":"CRF Text1","type":"Alternate Question Text","description":"Does the patient have a history of abdominal fistula, gastrointestinal perforation, intra-abdominal abscess, bowel obstruction, or gastric outlet obstruction?","url":null,"context":"CTEP"},{"name":"COG_CRF_TEXT_1","type":"Alternate Question Text","description":"Does the patient have a history of abdominal fistula, gastrointestinal perforation or intra-abdominal abscess within indicated time period","url":null,"context":"COG"},{"name":"CRF Text7","type":"Alternate Question Text","description":"History of abdominal fistula or intra-abdominal abscess requiring a major surgical procedure within 28 days prior to step 2 registration","url":null,"context":"NRG"},{"name":"CRF Text3","type":"Alternate Question Text","description":"Prior bowel obstruction, abdominal fistula, gastrointestinal perforation, or intra-abdominal abscess","url":null,"context":"CTEP"},{"name":"CRF text 9","type":"Alternate Question Text","description":"History of abdominal fistula, gastrointestinal perforation or intra-abdominal abscess within 28 days prior to registration","url":null,"context":"NRG"},{"name":"CRF Text8","type":"Alternate Question Text","description":"History of abdominal fistula or intra-abdominal abscess  within 28 days prior to registration","url":null,"context":"NRG"},{"name":"COG_CRF_TEXT_2","type":"Alternate Question Text","description":"Does the patient have a history of fistula, gastrointestinal ulcer or perforation, or intra-abdominal abscess within indicated time period","url":null,"context":"COG"},{"name":"eligibility question","type":"Alternate Question Text","description":"Does the patient have a history of abdominal fistula within 6 months prior to study entry that has not been surgically repaired or she is considered high risk for recurrence of fistula?","url":null,"context":"NRG"},{"name":"NRG CRF Text10","type":"Alternate Question Text","description":"Does the patient have a history of abdominal fistula within 6 months prior to study entry that has not been surgically repaired/healed  or she is considered high risk for recurrence of fistula?","url":null,"context":"NRG"},{"name":"CRF Text 11","type":"Alternate Question Text","description":"Does the patient have a history of abdominal/pelvic or tracheoesophageal fistula or gastrointestinal perforation and/or abscess within 6 months prior to the anticipated Cycle 1, Day 1","url":null,"context":"CTEP"},{"name":"COG CRF TEXT 3","type":"Alternate Question Text","description":"Does patient have a history of abdominal fistula, gastrointestinal perforation, or intra-abdominal abscess within 28 days of study enrollment?","url":null,"context":"COG"},{"name":"CRF Text 12","type":"Alternate Question Text","description":"Does the patient have a history of abdominal fistula?","url":null,"context":"CTEP"},{"name":"CRF Text 13","type":"Alternate Question Text","description":"Does the patient have a history of abdominal/pelvic or tracheoesophageal fistula or gastrointestinal perforation and/or abdominal/pelvic abscess within 6 months prior to the anticipated Cycle 1, Day 1","url":null,"context":"CTEP"},{"name":"CRF Text 14","type":"Alternate Question Text","description":"Does the patient have a history of abdominal fistula, gastrointestinal perforation or intra-abdominal abscess within 3 months prior to study registration?","url":null,"context":"NRG"},{"name":"Alliance - 1","type":"Alternate Question Text","description":"Prior perforation, abscess or fistula?","url":null,"context":"Alliance"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9A0FEE6C-45A8-EAE2-E040-BB89AD43297F","latestVersionIndicator":"Yes","beginDate":"2011-01-17","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2011-01-17","modifiedBy":"CLOHNES","dateModified":"2022-08-11","changeDescription":"Replaced VD Eligibility Ind-2 2018257v1 with VD ID#3506068 - Yes No Indicator - dbw","administrativeNotes":"8/11/22 added AQT for Alliance cjl;","unresolvedIssues":null,"deletedIndicator":"No"}}